| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.32 | 0.08 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |